Clinical Trials Logo

Contraception clinical trials

View clinical trials related to Contraception.

Filter by:

NCT ID: NCT06067256 Recruiting - Contraception Clinical Trials

A Multicentre, Prospective, Open-label, Non-comparative Study

Start date: July 20, 2023
Phase: Phase 4
Study type: Interventional

As there are no recent studies conducted in Italy on the profile of this COC, the purpose of this study is to evaluate its efficacy and tolerability in a given subset of women residing in Italy that are in need of contraception. Evaluate the cycle control: breakthrough bleeding (bleeding and/or spotting between cyclically regular onset of menses) of monophasic oral contraceptive pill Effimia® (NGM250 + EE35) in a population of women residing in Italy.

NCT ID: NCT06048536 Recruiting - Contraception Clinical Trials

Dose-finding Study of MR-130A-01 Contraceptive Transdermal Patch

Start date: March 7, 2023
Phase: Phase 2
Study type: Interventional

A single-center, randomized, open-label, parallel-group, multi-arm, phase II clinical trial in healthy women aged 18 to 35 years who have a documented ovulatory cycle prior to randomization.

NCT ID: NCT06042556 Completed - Contraception Clinical Trials

IUD Self-Removal: Evaluating an Online Guide for Self-removal in Clinical and Non-clinical Settings

Start date: April 3, 2021
Phase: N/A
Study type: Interventional

Investigators previously developed a guide to help people with IUD self-removal. In this randomized study, the goal is to see if this guide makes it easier for IUD-users to remove their own IUDs. The main question the study aims to answer is: -Does use of the previously developed IUD self-removal guide increase rates of self removal? Participants will: - Complete a pre-study survey - Be randomized to self-removal with use of the guide or no additional resource - Self-select participation at home or in clinic - Attempt IUD self-removal either at home or in clinic - Complete a post-study survey. Investigators will compare rates of successful self-removal between those randomized to the guide to those randomized to no additional resource to see if increases success.

NCT ID: NCT06028555 Recruiting - Contraception Clinical Trials

International Active Surveillance Study: Native Estrogen Estetrol (E4) Safety Study

INAS-NEES
Start date: June 28, 2023
Phase:
Study type: Observational

Multinational, comparative, prospective, active surveillance study that follows two cohorts. The primary objective of the study is to characterize and compare the risks of E4/Drospirenone (DRSP) with levonorgestrel-containing combined oral contraceptives (EE/LNG) in a study population that is representative of the actual users of these preparations. The main clinical outcome of interest is venous thromboembolism (VTE), specifically deep venous thrombosis (DVT) and pulmonary embolism (PE). Secondary objectives include measuring the occurrence of unintended pregnancy, assessing the risk of arterial thromboembolism (ATE), describing the drug utilization pattern, describing the baseline risk profile for VTE and ATE, and investigating outcomes associated with foetal exposure to E4/DRSP.

NCT ID: NCT06019533 Recruiting - Contraception Clinical Trials

A Trial on Contraceptive Efficacy, Safety and Tolerability of LVDS (Levonorgestrel Vaginal Delivery System) During 13 Cycles

Start date: August 9, 2023
Phase: Phase 3
Study type: Interventional

Multicentre, single arm phase III trial to assess the pearl index of LVDS. The trial lasts 13 cycles.The assessments include (but are not limited to) recording demographic data, pregnancy tests, gynaecological examinations, laboratory tests and a quality of life questionnaire. Adolescents will undergo DXA scans to measure bone mineral density (at selected sites only). The women will be provided with an e-diary app for their smartphone, to record IP use and vaginal bleeding.

NCT ID: NCT06009783 Recruiting - Contraception Clinical Trials

Utility of ChatGPT in Pre-vasectomy Counselling in an Office-based Setting

Start date: August 30, 2023
Phase: N/A
Study type: Interventional

The investigators wish to perform a pilot study at the Manitoba Men's Health Clinic to assess if pre-vasectomy counseling with ChatGPT can safely streamline the consultation process by reducing visit times, while increasing patient satisfaction with the consultation process.

NCT ID: NCT05994599 Recruiting - Contraception Clinical Trials

Comparative Bioavailability Study of Ethinyl Estradiol/Etonogestrel Vaginal Ring

Start date: July 28, 2023
Phase: Phase 1
Study type: Interventional

Single Dose Crossover Comparative Bioavailability Study of Ethinyl Estradiol/Etonogestrel Vaginal Ring (Delivering 0.015 mg/0.12 mg Per Day) Worn for 21 Days in Healthy Female Subjects

NCT ID: NCT05988983 Not yet recruiting - Contraception Clinical Trials

The Over The Counter Pill National Study

Start date: November 2023
Phase:
Study type: Observational

This is a prospective cohort study of individuals purchasing the oral contraceptive pill over the counter (OTC) in pharmacies in 32 US states. The comparison group is people receiving a prescription (Rx) for oral contraception. Both groups will be followed for one year to examine contraceptive continuation rates. This study will also identify who is using the pill OTC and why and evaluate differences in pregnancy intention and measures of contraceptive agency between the two groups.

NCT ID: NCT05977751 Recruiting - Contraception Clinical Trials

Prospective Multi-Center Trial for FemBloc Permanent Birth Control

FINALE
Start date: October 31, 2023
Phase: N/A
Study type: Interventional

Prospective, multi-center, international, unblinded, single-arm trial of subjects undergoing FemBloc followed by ultrasound confirmation test.

NCT ID: NCT05927194 Recruiting - Contraception Clinical Trials

Using the Connect: Game Based Intervention

UTC
Start date: June 15, 2023
Phase: N/A
Study type: Interventional

The study aims to implement Using the Connect (UTC), an innovative, game-based intervention designed to increase protective factors and decrease adolescent pregnancies. This intervention will be implemented in Texas middle schools and community-based organizations. The long-term goal is to promote optimal health in youth and prevent adolescent pregnancy in populations disproportionately impacted by adolescent pregnancy and sexually transmitted infection (STI) rates. The short-term objective is to conduct a robust, multi-site clustered randomized controlled trial to evaluate implementation outcomes and the impact of UTC, a novel theory-based game developed using powerful and effective human-centered design (HCD) strategies, on intention to delay sexual activity.